Indeed, since SUDEP is genetically complex and its predisposing factors in humans remain unknown, the validation of Kv1.1 as a potential biomarker and therapeutic target for SUDEP could be helpful to stratify patients at risk, adopt appropriate preventive measures and plan genotype-driven therapeutic approaches. This evidence concerns the gene KCNA1 and Sudden unexpected death in epilepsy.